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for NMDA-mediated signal transduction
Norman J. Kennedy,1 Gilles Martin,2 Anka G. Ehrhardt,1 Julie Cavanagh-Kyros,1 Chia-Yi Kuan,3
Pasko Rakic,4 Richard A. Flavell,5 Steven N. Treistman,2 and Roger J. Davis1,6
1Howard Hughes Medical Institute and Program in Molecular Medicine, University of Massachusetts Medical School,
Worcester, Massachusetts 01605, USA; 2Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical
School, Worcester, Massachusetts 01605, USA; 3Division of Developmental Biology, Cincinnati Children’s Hospital
Research Foundation, Cincinnati, Ohio 45229, USA; 4Department of Neurobiology, Yale University School of Medicine,
Yale University, New Haven, Connecticut 06520, USA; 5Howard Hughes Medical Institute and Section of Immunobiology,
Yale University School of Medicine, Yale University, New Haven, Connecticut 06520, USA
JIP scaffold proteins are implicated in the regulation of protein kinase signal transduction pathways. To test
the physiological role of these scaffold proteins, we examined the phenotype of compound mutant mice that
lack expression of JIP proteins. These mice were found to exhibit severe defects in N-methyl-D-aspartic acid
(NMDA) receptor function, including decreased NMDA-evoked current amplitude, cytoplasmic Ca++, and gene
expression. The decreased NMDA receptor activity in JIP-deficient neurons is associated with reduced
tyrosine phosphorylation of NR2 subunits of the NMDA receptor. JIP complexes interact with the SH2
domain of cFyn and may therefore promote tyrosine phosphorylation and activity of the NMDA receptor.
We conclude that JIP scaffold proteins are critically required for normal NMDA receptor function.
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The JIP1 scaffold protein is implicated in the assembly
and coordination of cJun N-terminal kinase (JNK) signal-
ing modules that include the mitogen-activated protein
(MAP) kinase kinase MKK7 and the mixed-lineage ki-
nase group of MAP kinase kinase kinases (Dickens et al.
1997; Whitmarsh et al. 1998). Indeed, studies of JIP1-
deficient mice confirm that this scaffold protein is es-
sential for some forms of stress-induced JNK activation
(Morrison and Davis 2003). Thus, JIP1 is required for JNK
activation and neuronal death in response to ischemia in
vitro and stroke in vivo (Whitmarsh et al. 2001; Im et al.
2003) and for JNK-mediated insulin resistance in type II
diabetes (Jaeschke et al. 2004).
Although JIP1 is established to be important for JNK
regulation, it appears that JIP1 may also have other
physiological functions. For example, JIP1 is implicated
in both the AKT and SRC signaling pathways (Kim et al.
2003; Nihalani et al. 2007). Furthermore, JIP1 may also
act as an adapter protein that links the kinesin-1 motor
protein to cargoes (Verhey et al. 2001; Whitmarsh et al.
2001). JIP1 may therefore influence the kinesin-mediated
localization of cargo molecules and organelles within the
cell. Proposed cargoes are represented by the low-density
lipoprotein receptor-related protein LRP8 (Verhey et al.
2001) and organelles, including mitochondria and synap-
tic vesicles (Horiuchi et al. 2005). Together, these obser-
vations suggest that JIP1-deficient mice should have ma-
jor physiological defects. However, JIP1-deficient mice
exhibit only a limited spectrum of defects, including the
response to ischemia (Whitmarsh et al. 2001; Im et al.
2003) and metabolic stress (Jaeschke et al. 2004).
The analysis of additional phenotypes of JIP1-deficient
mice may be compromised by partial compensation me-
diated by the scaffold protein JIP2 (Yasuda et al. 1999).
JIP1 and JIP2 are structurally related scaffold proteins
that share a similar tissue distribution, including high
levels of expression in the brain. To test the role of these
scaffold proteins, we examined the phenotype of com-
pound mutant mice that lack expression of both JIP1 and
JIP2. This analysis led to the discovery that the JIP1/2
group of scaffold proteins is critically required for normal
N-methyl-D-aspartic acid (NMDA) receptor function.
Results
Creation of JIP-deficient mice
We disrupted the murine Jip2 gene using homologous
recombination in embryonic stem cells (Fig. 1A). Chi-
meric mice prepared with these cells transmitted the
disrupted Jip2 allele through the germline (Fig. 1B,C).
The presence of JIP1 in mice that lack expression of JIP2
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may result in compensation of phenotypes that might be
caused by JIP2 deficiency. Indeed, it was observed that
the expression of JIP1 was increased in the brain of
Jip2−/− mice compared with wild-type mice (Fig. 1C). We
therefore mated JIP1-deficient mice with JIP2-deficient
mice to create compound mutant animals (Fig. 2A).
Genotype analysis of the double-knockout mice con-
firmed that the Jip1 and Jip2 genes were disrupted (Fig.
2B), and immunoblot analysis demonstrated that no JIP1
or JIP2 protein was detected (Fig. 2C). As expected (Whit-
marsh et al. 2001; Im et al. 2003), JIP deficiency caused
defects in JNK activity in primary neurons in vitro (Fig.
2D,E) and the brain in vivo (Fig. 2F).
The JIP1/2-deficient mice were severely ataxic. Al-
tered cerebellar function is a frequent cause of ataxia
(Grusser-Cornehls and Baurle 2001). We therefore exam-
ined the cerebellum of wild-type and JIP1/2-deficient
mice. This analysis demonstrated that the cerebellar
morphology of JIP1/2-deficient mice exhibited the ex-
pected foliation and localization of Purkinje cells. How-
ever, defects in Purkinje cell dendritic arborization were
found in the JIP1/2-deficient mice (Supplementary Fig.
S1A,B). In contrast, no defects in the morphology of cor-
tical or hippocampal neurons were detected (Supplemen-
tary Fig. S1B).
The Purkinje cell defect in dendritic arborization ob-
served in JIP1/2-deficient mice could be cell autono-
mous; alternatively, this defect may be a consequence of
decreased neurotrophin signaling or decreased synaptic
activity (Sotelo 2004). Purkinje cells are an important
source of mitogen (sonic hedgehog) that is required for
the proliferation of cerebellar granule neurons (CGN)
(Sotelo 2004). We therefore anticipated that JIP1/2-defi-
cient mice may exhibit defects in CGN proliferation.
However, examination of CGN in the external granular
layer demonstrated no defects in proliferation (Supple-
mentary Fig. S1A). Nevertheless, defects in CGN, which
make mutiple synaptic connections to Purkinje cells,
could contribute to the altered Purkinje cell dendritic
arborization observed in JIP1/2-deficient mice.
Effect of JIP deficiency on kinesin cargo localization
We examined primary CGN isolated from wild-type and
JIP1/2-deficient mice. No differences in morphology be-
tween wild-type and mutant CGN were detected (Figs. 3,
4; Supplementary Fig. S2). The JIP1 and JIP2 proteins can
bind the light chain of kinesin-1, and this interaction
results in microtubule-directed transport of JIP proteins
to growth cones in cultured neurons (Verhey et al. 2001;
Whitmarsh et al. 2001). It is therefore possible that
JIP1/2 may function as adapter proteins that recruit
cargo proteins to kinesin-1. Potential cargoes include the
low-density lipoprotein receptor-related protein LRP8
(Verhey et al. 2001). However, no defect in the localiza-
tion of LRP8 to neuronal growth cones was detected (Fig.
3A). LRP8 is known to localize to the apical surface of
epithelial cells in the epididymus, a tissue that expresses
JIP2 but not JIP1 (Stockinger et al. 2000). We therefore
examined LRP8 localization in the epididymus of wild-
type and JIP2-deficient mice. No defect in the apical lo-
calization of LRP8 in the epididymal epithelial cells of
JIP-deficient mice was detected (Fig. 3B). These data sug-
gest that JIP1/2 may play either no role, or a redundant
role, as adapter proteins in kinesin-mediated subcellular
localization of LRP8.
The JIP1/2 scaffold proteins have also been implicated
as adapter molecules that mediate kinesin-mediated lo-
calization of organelles, including mitochondria and syn-
aptic vesicles (Horiuchi et al. 2005). However, no defects
in the subcellular distribution of mitochondria or the
synaptic vesicle marker Synapsin I were observed in
JIP1/2-deficient CGN (Fig. 3C,D). JIP1 and JIP2 therefore
do not play a nonredundant role in determining the sub-
cellular localization of mitochondria or synaptic
vesicles. Control studies demonstrated that JIP1/2-defi-
ciency also did not affect the subcellular localization of
the glutamate receptor GluR2 (Fig. 3D).
JIP-deficient neurons exhibit defects in NMDA
receptor signaling
To test the function of JIP1/2-deficient CGN, we exam-
ined the response of these neurons to the glutamate re-
Figure 1. Targeted disruption of the murine Jip2 gene. (A) The
structures of the wild-type Jip2 genomic locus, the targeting
vector, and the disrupted Jip2 gene are schematically illustrated.
Exons are represented with boxes; noncoding regions (white)
and coding regions (black) are indicated. The region that en-
codes the JNK-binding domain (JBD), the probe used for South-
ern blot analysis, the NeoR and TK cassettes, and some restric-
tion sites (Not1 [N], EcoR1 [E], Spe1 [S], BamH1 [B], and HindIII
[H]) are indicated. (B) Identification of JIP2-deficient mice. Wild-
type (+/+), heterozygous (−/+), and homozygous (−/−) knockout
mice were identified using PCR analysis of genomic tail DNA.
The Jip2−/− mice were slightly smaller than wild-type litter-
mates. The male Jip2−/− mice were found to be infertile. (C)
Brain lysates prepared from Jip2+/+, Jip2−/+, and Jip2−/− mice were
examined by immunoblot analysis using antibodies to JIP1,
JIP2, JNK1/2, and -Tubulin.
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ceptor agonist NMDA. Treatment with NMDA caused
an increase in the cytoplasmic concentration of Ca++ in
wild-type neurons, but not in JIP1/2-deficient neurons
(Fig. 4C,D). We confirmed that this Ca++ response was
initiated by the NMDA receptor by demonstrating that
the selective NMDA receptor antagonist D(-)-2-amino-5-
phosphonopentanoic acid (APV) strongly suppressed the
NMDA-induced Ca++ response (Fig. 4E). The reduced
NMDA-induced Ca++ response of JIP1/2-deficient neu-
rons (Fig. 4C,D) may reflect a defect in NMDA receptor
signaling or may be caused by a more generalized defect
in Ca++ homeostasis. To distinguish between these pos-
sibilities, we examined the effect of depolarization
caused by addition of KCl to the culture medium. These
Figure 2. Creation of Jip1 and Jip2 compound
mutant mice. (A) A cohort of 69 animals ob-
tained by mating of Jip1−/− Jip2−/+ mice was ex-
amined by genotype analysis. For each genotype
group, the number, frequency of mice, and ex-
pected frequency based on Mendelian inherit-
ance are presented. The JIP1/2-deficient mice
were smaller than littermate control mice, ex-
hibited severe ataxia, and did not survive after
weaning. (B) Genotype analysis of wild-type and
compound mutant Jip1−/− Jip2−/− mice was per-
formed using PCR primers to examine the Jip1,
Jip2, Jnk1, and Jnk2 genes. (C) Protein extracts
prepared from the brains of wild-type mice,
Jip1−/− Jip2−/+ mice, and Jip1−/− Jip2−/− mice were
examined by immunoblot analysis using anti-
bodies to JIP1, JIP2, JNK1/2, and -Tubulin. (D,E)
Primary cortical neurons were exposed to UV ra-
diation (60 J/m2) and incubated for 45 min. The
neurons were stained with antibodies to phos-
pho-JNK (green) and -Tubulin (red). (Bottom
panels) Merged images of phospho-JNK and
-Tubulin are shown. (Left panels) Background
staining was evaluated in studies of neurons
stained without the primary antibody. (D) Rep-
resentative immunofluorescence images are pre-
sented. JNK activation was quantitated by mea-
surement of the ratio of fluorescence intensity of
phospho-JNK and -Tubulin staining (mean ± SD;
n = 10). (E) A statistically significant (P < 0.05) re-
duction of UV-stimulated JNK activation in JIP1/
2-deficient neurons compared with wild-type
neurons was detected. (F) Protein extracts were
prepared from the cerebellum of wild-type mice
and Jip1−/− Jip2−/− mice. (E, top panel) JNK activ-
ity was measured in an in vitro protein kinase
assay using [-32P]ATP and c-Jun as substrates.
(Bottom panels) Immunoblot analysis confirmed
that these lysates contain equal amounts of
JNK1/2 and -Tubulin.
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studies indicated that KCl-induced depolarization
caused similar increases in cytoplasmic Ca++ in both
wild-type and JIP1/2-deficient neurons (Fig. 4F). These
data indicate that JIP1/2-deficient neurons may have de-
fects in NMDA receptor signaling. Indeed, the mutant
neurons exhibited severely reduced NMDA-induced
gene expression. Thus, NMDA increased the expression
of brain-derived neurotrophic factor (BDNF) and c-Fos
mRNA in wild-type neurons, but this response was sup-
pressed in JIP1/2-deficient neurons (Fig. 4G,H). These
data demonstrate that JIP1/2-deficient neurons may ex-
hibit a major defect in signal transduction mediated by
NMDA receptors. To confirm this conclusion, we per-
formed electrophysiological analysis of NMDA receptor
function in wild-type and JIP-deficient neurons. NMDA-
induced whole-cell currents in JIP1/2-deficient CGN ex-
hibited markedly decreased current amplitude and an in-
creased rate of current decay (desensitization) compared
with wild-type neurons (Fig. 5). Analysis of neurons iso-
lated from mice lacking expression of single JIP isoforms
demonstrated that JIP1 and JIP2 have partially redundant
functions, but JIP2 primarily governs the magnitude of
the initial current amplitude, and JIP1 primarily delays
the subsequent decay of the NMDA-induced current
(Fig. 5).
The decreased whole-cell NMDA receptor current ob-
served in JIP1/2-deficient neurons could be the result of
a defect in NMDA receptor expression. However, immu-
noblot analysis of the NR1, NR2A, and NR2B subunits
of the NMDA receptor indicated that the JIP1/2-defi-
cient cerebellum does not express lower levels of NMDA
receptor subunits than wild-type mice (Fig. 6A). These
data were confirmed by measurement of NMDA recep-
tor subunit mRNA expression in primary cultures of
CGN (Fig. 6B). Reduced NMDA receptor expression
therefore does not account for the decreased NMDA re-
Figure 3. Effect of JIP deficiency on cargo localization. (A) Immunofluorescence microscopy of primary neurons prepared from
wild-type (WT) and Jip1−/− Jip2−/− mice demonstrated a similar localization of LRP8 in growth cones. Representative images are
presented of the growth cones of primary cortical neurons stained with phalloidin (filamentous actin, green) and an antibody to
-Tubulin (red) (top panels) or with antibodies to LRP8 (green) and -Tubulin (red) (bottom panels). (B) Sections of the epididymis were
examined by staining with an antibody to LRP8 (brown). No difference in LRP8 localization between wild-type and Jip2−/− mice was
detected. (C) The mitochondria of wild-type and Jip1−/− Jip2−/− CGN were labeled with a dye (Mitotracker), and a confocal microscope
was used to acquire fluorescence (top panels) and Nomarski (bottom panels) images. No difference in the localization of mitochondria
between wild-type and JIP1/2-deficient CGN was detected. (D) Wild-type and Jip1−/− Jip2−/− CGN were stained with an antibody to
synapsin I (top panels) or an antibody to GluR2 plus -Tubulin (bottom panels). Nuclear DNA was stained with DAPI (blue).
JIP regulation of NMDA signaling
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ceptor function observed in JIP1/2-deficient mice. How-
ever, it is possible that the cell surface location of
NMDA receptors may be decreased in JIP1/2-deficient
neurons compared with wild-type neurons. To test this
hypothesis, we examined the cell surface expression of
the obligate NMDA receptor subunit NR1 by immuno-
fluorescence analysis. Studies of nonpermeabilized cells
demonstrated that both wild-type and JIP1/2-deficient
neurons expressed a similar amount of cell surface NR1
(Fig. 6C,D). The cell surface expression of Reelin was
also similar in wild-type and JIP1/2-deficient neurons
(Fig. 6D). Control studies using permeabilized cells indi-
cated that the distribution of the total population of NR1
was similar in wild-type and JIP1/2-deficient neurons
(Fig. 6D). However, the amount of NR1 detected by im-
munoblot analysis (Fig. 6A) and immunofluorescence
microscopy of permeabilized neurons (Fig. 6D) of JIP1/2-
deficient neurons was slightly larger than that detected
in wild-type neurons. Since the cell surface expression of
NR1 was not affected by JIP1/2 deficiency (Fig. 6C), these
data indicate that the mutant neurons express a higher
amount of intracellular NR1. Together, these data indi-
cate that the reduced NMDA receptor function observed
in JIP1/2-deficient neurons (Fig. 5) was not caused by
decreased expression of NMDA receptors.
JIP-deficient neurons exhibit defects in NMDA
receptor tyrosine phosphorylation
What mechanism might account for the requirement of
JIP scaffold proteins for the normal function of the
NMDA receptor? It is established that the NMDA recep-
tor is subject to regulatory phosphorylation of NR1 and
NR2 subunits on Ser residues by several protein kinases
Figure 4. Defective NMDA responses in
Jip1/2 compound mutant mice. (A,B) Phase
contrast images of primary cultures of
wild-type and Jip1−/− Jip2−/− CGN are illus-
trated in A. (B) The CGN were labeled
with calcein and imaged by fluorescence
microscopy. (C,D) CGN labeled with the
calcium indicator dye Fluo-4 AM were
treated with NMDA (50 µM), and cyto-
plasmic calcium was examined by fluores-
cence microscopy. (C) The images pre-
sented represent cells prior to NMDA
treatment (control) and after treatment
with NMDA. (D) The intracellular Ca++
concentration is presented as the mean ± SD
(n = 10), and statistically significant differ-
ences (P < 0.05) are indicated with an as-
terisk. (E) The effect of treatment of wild-
type CGN with the selective NMDA re-
ceptor antagonist APV (12.5 µM) was
examined. The maximum NMDA-in-
duced Ca++ response was examined using
the indicator dye Fluo-4 AM (mean ± SD;
n = 10). Statistically significant differences
(P < 0.01) are indicated with an asterisk. (F)
The effect of KCl-mediated depolarization
on the Ca++ response of wild-type and JIP1/
2-deficient CGN was examined. The CGN
were treated with KCl (70 mM final con-
centration), and the maximum Ca++ re-
sponse was examined using the indicator
dye Fluo-4 AM (mean ± SD; n = 10). No
statistically significant differences (P < 0.05)
were detected. (G,H) NMDA-regulated
gene expression was examined in primary
cultures of CGN prepared from wild-type
and compound mutant Jip1−/− Jip2−/− mice.
The neurons were treated with NMDA
(100 µM) for the indicated times, and RNA
was isolated. The expression of c-Fos and
BDNF mRNA was examined by quantita-
tive PCR (TaqMan assay) and is presented
as the mean ± SD (n = 3). Statistically sig-
nificant differences are indicated with as-
terisks (P < 0.01).
Kennedy et al.
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(including PKA, CAMK II, and CK2) (Llansola et al. 2005)
and also Tyr phosphorylation of NR2 subunits mediated
by members of the SRC family (Salter and Kalia 2004).
The reduced NMDA receptor function in JIP1/2-defi-
cient neurons might therefore be mediated by altered
regulatory phosphorylation of the NMDA receptor. To
test this hypothesis, we examined NR2B phosphoryla-
tion in wild-type and JIP1/2-deficient neurons. Immuno-
blot analysis demonstrated that JIP deficiency caused
markedly decreased Tyr phosphorylation of NR2B (Fig.
7A,B), an NMDA receptor substrate that is established to
be phosphorylated by the cFyn tyrosine kinase in vivo
(Nakazawa et al. 2001). In contrast, no difference in
NR2B phosphorylation on Ser1303 (Omkumar et al.
1996) was detected (Fig. 7A). Loss of tyrosine phosphory-
lation of NR2B is established to cause reduced NMDA
receptor signaling (Salter and Kalia 2004) and may there-
fore contribute to the decreased NMDA receptor func-
tion observed in JIP1/2-deficient neurons (Fig. 5).
Regulatory tyrosine phosphorylation of NR2A and
NR2B is largely mediated by the cFyn tyrosine kinase
(Tezuka et al. 1999; Nakazawa et al. 2001). Previous
studies have demonstrated that JIP proteins may act as
scaffolds for components of the JNK, AKT, and SRC sig-
naling pathways (Whitmarsh et al. 1998; Kim et al. 2003;
Nihalani et al. 2007). In addition, it is established that JIP
proteins are localized at post-synaptic densities in neu-
rons (Pellet et al. 2000). Indeed, immunofluorescence
analysis of CGN demonstrated the peripheral localiza-
tion of JIP proteins (Supplementary Fig. S3). Thus, JIP
proteins, like other kinase scaffolds (Smith et al. 2006),
can form multifunctional complexes. We therefore tested
whether JIP proteins might also interact with cFyn. In-
deed, JIP1 was tyrosine-phosphorylated and cFyn coim-
munoprecipitated with JIP1 (Fig. 7D,E). Deletion analy-
sis indicated that the SH2 domain of cFyn mediates the
interaction with JIP1 and JIP2 (Fig. 7C). Together, these
data suggest that JIP proteins may function to recruit the
cFyn tyrosine kinase to NMDA receptor complexes.
Discussion
The results of this study demonstrate that JIP scaffold
proteins are important for the normal activity of NMDA
receptors. It is established that JIP proteins are localized
at post-synaptic densities in neurons (Pellet et al. 2000),
but the mechanism that accounts for the functional inter-
action of JIP proteins with NMDA receptors is unclear.
One possibility is that the PTB domain of JIP1 and JIP2
may contribute to this regulatory process. Indeed, sev-
eral ligands for this PTB domain have been described, in-
cluding the low-density lipoprotein receptor-related pro-
tein LRP8 (Stockinger et al. 2000), the Rac exchange factor
Tiam1 (Buchsbaum et al. 2002), and the Ras exchange
factor Ras-Grf (Buchsbaum et al. 2002). Interestingly, all
three of these proteins (LRP8, Tiam1, and Ras-Grf) are
known to bind NMDA receptors (Krapivinsky et al. 2003;
Beffert et al. 2005; Tolias et al. 2005). These proteins may
therefore recruit JIP/cFyn complexes to the NMDA recep-
tor to regulate NR2 subunit tyrosine phosphorylation.
The interaction of LRP8 with JIP1/2 is particularly in-
triguing because it is established that the site of interac-
tion of the JIP1/2 PTB domain with the cytoplasmic do-
main of LRP8 is encoded by exon 19 (Stockinger et al.
2000). This is an alternative spliced exon that is selec-
tively included in Lrp8 mRNA in response to neuronal
activity (Beffert et al. 2005). Thus, only exon 19-positive
LRP8 can bind to the JIP1/2 PTB domain (Stockinger et
al. 2000). Gene targeting studies have demonstrated that
ablation of Lrp8 exon 19 results in mice that exhibit
defects in NMDA receptor signaling associated with
markedly decreased NR2 subunit tyrosine phosphoryla-
tion (Beffert et al. 2005). Exon 19-positive LRP8 may
therefore regulate NMDA receptor activity. Interest-
ingly, the defect in NMDA receptor signaling and NR2
subunit phosphorylation caused by loss of Lrp8 exon 19
(Beffert et al. 2005) is similar to that caused by com-
pound mutation of JIP1/2 (Fig. 5). Together, these data
suggest that the physical interaction between the JIP1/2
PTB domain and the segment of the LRP8 cytoplasmic
tail encoded by Lrp8 exon 19 is functionally significant.
Indeed, it is possible that JIP/cFyn complexes may me-
diate the effects of LRP8 on NMDA receptors. Engage-
ment of cell surface LRP8 by its ligand Reelin may trig-
Figure 5. Electrophysiological analysis of CGNs from JIP-defi-
cient mice. (A) NMDA-induced whole-cell currents in primary
CGN isolated from wild-type, Jip1−/−, Jip2−/−, and compound
mutant Jip1−/− Jip2−/− mice are illustrated. (B) The amplitude of
the NMDA-induced whole-cell current was normalized for each
genotype and superimposed to compare the rate of current decay
(desensitization). The rate was calculated by fitting the data to
a single exponential and the time constant (in seconds) is pre-
sented. (C,D) The NMDA current amplitude (C) and the rate of
desensitization (D) were quantitated (mean ± SD; n = 9–24). The
current amplitude and desensitization were significantly re-
duced in JIP-deficient neurons compared with wild-type neu-
rons (P < 0.0005, indicated with asterisks).
JIP regulation of NMDA signaling
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ger this regulatory pathway to control NMDA receptor
function (Beffert et al. 2005).
The postnatal role of LRP8 to regulate NMDA receptor
activity requires Lrp8 exon 19 (Beffert et al. 2005). How-
ever, LRP8 also plays an important developmental role
in determining the positioning of neurons in the brain
(Trommsdorff et al. 1999). Mice lacking the ligand Ree-
lin (reeler mice) or mice with targeted ablation of the
Lrp8 gene exhibit marked defects in neuronal position-
ing (Trommsdorff et al. 1999). However, neither targeted
ablation of the alternatively spliced Lrp8 exon 19 (Beffert
et al. 2005) nor compound deficiency of JIP1/2 (Supple-
mentary Fig. S1A) causes a reeler-like neuronal position-
ing defect during development. Thus, the JIP1/2 PTB do-
main interaction with the cytoplasmic tail of LRP8 does
not play a role in the early developmental function of
LRP8 to regulate neuronal positioning.
A critical role for cFyn in NMDA receptor regulation
is established by the finding that cFyn−/− mice exhibit
severely reduced tyrosine phosphorylation of NR2A (Te-
zuka et al. 1999) and NR2B (Nakazawa et al. 2001) and
display major defects in long-term potentiation and spa-
tial learning (Grant et al. 1992). Nevertheless, other
members of the SRC family of tyrosine kinases (includ-
ing Lck, Lyn, Src, and Yes) have also been implicated in
the regulation of NMDA receptor function (Salter and
Figure 6. NMDA receptor expression in JIP-deficient mice. (A,B) The expression of the NR1, NR2A, and NR2B subunits of the
NMDA receptor in the cortex and cerebellum of wild-type (WT) and compound mutant Jip1−/− Jip2−/− (KO) mice (6 and 10 d old) was
examined by immunoblot analysis, shown in A. (B) NMDA receptor subunit mRNA expression in CGN was measured by quantitative
RT–PCR. The data presented represent the mean ± SD (n = 5). No statistically significant differences between the wild-type and
mutant CGN were detected. The expression of NR2C, which is expressed in the cerebellum later in development (Sotelo 2004), was
not detected by immunoblot analysis. -Tubulin expression was examined as a loading control. (C,D) Wild-type and compound mutant
Jip1−/− Jip2−/− CGNs were fixed and processed for immunofluorescence analysis under nonpermeabilizing conditions (D, top and
bottom rows) or permeabilizing conditions (D, middle row). The localization of NR1, -Tubulin, and Reelin was examined by confocal
fluorescence microscopy. Staining with -Tubulin was employed as a control to confirm whether or not the neurons were permeabi-
lized. (C) The cell surface staining of NR1 was quantitated by measurement of puncta per square micrometer (mean ± SD; n = 10). No
statistically significant difference between wild-type and mutant neurons was detected (P < 0.05).
Kennedy et al.
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Kalia 2004). cFyn may therefore represent only one
member of a larger group of SRC family kinases that are
recruited by JIP scaffold proteins. This function of JIP
proteins may be coordinated with the actions of other
scaffold proteins that can bind SRC family kinases and
are present within post-synaptic densities (e.g., PSD-95
or RACK1) (Tezuka et al. 1999; Yaka et al. 2002). Since
Jip1−/− and Jip2−/− neurons exhibit different defects in
NMDA receptor function (Fig. 5), it is possible that these
JIP scaffold proteins may cooperate by influencing differ-
ent steps in the regulatory process. It is also possible that
the structurally unrelated scaffold proteins JIP3 and JIP4
may also contribute to NMDA receptor regulation.
In conclusion, we demonstrate that JIP1/2 scaffold pro-
teins represent novel components of the NMDA receptor
regulatory network required for normal NMDA-medi-
ated signal transduction.
Materials and methods
Mice
A 129/SvJ strain Jip2 genomic clone was isolated from a FixII
phage library (Stratagene) by hybridization analysis using a
probe derived from a Jip2 cDNA. A targeting vector designed to
disrupt the Jip2 gene (Fig. 1A) was constructed using standard
techniques. Embryonic stem (ES) cells (strain 129SvJ) were elec-
troporated with this vector and selected with 200 µg/mL G418
and 2 µM gangcyclovir. Jip2−/+ ES cell clones identified by
Southern blot analysis were injected into C57BL/6J blastocysts
to create chimeric mice that were used to obtain germline trans-
mission of the disrupted Jip2 allele. The Jip1 (Whitmarsh et al.
2001) and Jip2 knockout mice were backcrossed to the C57BL/6J
strain (Jackson Laboratories). Homozygous and compound mu-
tant mice were obtained by breeding. Immunoblot analysis in-
dicated that the Jip1 and Jip2 gene disruption caused loss of
expression of full-length JIP1/2 proteins and did not result in the
detection of JIP protein fragments (Supplementary Fig. S4). The
mice were housed in a facility accredited by the American As-
sociation for Laboratory Animal Care (AALAC). The Institu-
tional Animal Care and Use Committee (IACUC) of the Uni-
versity of Massachusetts approved all studies using animals.
Genotyping
Genomic DNA was examined using a PCR assay to detect the
wild-type and disrupted Jip1 alleles (Whitmarsh et al. 2001).
Wild-type and disrupted Jip2 alleles were detected using two
different assays. First, Southern blot analysis of EcoR1 restricted
genomic DNA was performed by probing with a 300-base-pair
(bp) fragment of the Jip2 gene that was isolated by PCR using the
primers 5-CTTCATCACCAAACACCCGCT-3 and 5-GTCC
TTGCTCAAGCCACAGT-3. The wild-type and disrupted Jip2
alleles were detected as 15-kb and 12-kb bands, respectively.
Second, a PCR assay was employed using the primers 5-GTC
CCACAAGCTCCGATCCA-3, 5-CCTGCATCCTCAGAGT
CCGA-3, and 5-GTAGAAGGTGGCGCGAAGGG-3. The
wild-type and disrupted Jip2 alleles were amplified to yield 626-
bp and 288-bp DNA fragments, respectively.
Morphology
Histology was performed using 7-µm sections prepared from
tissue fixed in 10% formalin for 24 h, dehydrated, and embedded
in paraffin. Immunohistochemistry was performed by staining
tissue sections with the following antibodies: LRP8 (provided by
J. Nimpf, Medical University of Vienna, Vienna, Austria), cal-
bindin D (Sigma), GFAP (Chemicon), and BrdU (BioGenex). Im-
munocomplexes were detected using a biotinylated secondary
antibody (Biogenex), streptavidin-conjugated horseradish per-
oxidase (Biogenex), and the substrate 3,3-diaminobenzidene
(Vector Laboratories), followed by brief counterstaining with
Mayer’s hematoxylin (Sigma). Rapid Golgi staining was per-
formed with a kit (FD NeuroTechnologies) using the manufac-
turer’s recommendations.
Primary neurons
Embryonic day 16.5 mouse embryos were used to isolate pri-
mary cortical neurons. Briefly, cortices were placed in ice-cold
Hank’s buffered saline solution containing 20 mM HEPES (pH
7.3; HBSS) and minced with a sterile razor blade. Trypsin (In-
vitrogen) and DNase I (Sigma) were added to a final concentra-
tion of 0.25% and 1 mg/mL, respectively, and the tissue was
incubated at 37°C (20 min). The trypsin solution was removed,
and the minced tissue was triturated in neurobasal media con-
taining DNase I (1 mg/mL; Sigma) and soybean trypsin inhibitor
(0.5 mg/mL; Sigma) to obtain a single-cell suspension. Cortical
neurons were seeded in poly-D-lysine/laminin-coated chamber
slides (Becton Dickenson) in neurobasal medium containing
B27 supplements, 1% glutamine, 1% penicillin/streptomycin,
Figure 7. JIP deficiency causes defects in NMDA receptor ty-
rosine phosphorylation. (A,B) The amount of NR2B tyrosine
phosphorylation was examined in cerebellar extracts prepared
from wild-type and compound mutant Jip1−/− Jip2−/− mice (6 d
old) by immunoblot analysis of cell lysates (A) or phospho-Tyr
immunoprecipitates (B) with antibodies to phospho-Tyr, phos-
pho-Tyr-1472 NR2B, phospho-Ser1303 NR2B, and total NR2B.
(C) The SH2 domain of cFyn binds to JIP proteins. Immobilized
GST, GST-cFyn-SH2, and GST-cFyn-SH3 were incubated with
cell lysates. Bound JIP1 and JIP2 were detected by immunoblot
analysis. (D,E) Coimmunoprecitation analysis of JIP1b with
cFyn. Recombinant JIP1b and cFyn were expressed in COS cells.
The cell lysate and JIP1b or cFyn immunoprecipitates were ex-
amined by immunoblot analysis.
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and 10% fetal calf serum (Invitrogen). The following day, the
neurons were washed and refed with serum-free neurobasal me-
dium containing B27, glutamine, and antibiotics (Invitrogen).
The cortical neurons were cultured for 7 d in vitro prior to
analysis.
Cerebella from postnatal day 6 mouse pups were used to iso-
late primary CGN. Briefly, cerebella were placed in ice-cold
HBSS and minced with a sterile razor blade. Trypsin and DNase
I were added to a final concentration of 1% and 1 mg/mL, re-
spectively, and the tissue was incubated at 37°C (3 min). The
trypsin solution was removed, and the minced tissue was tritu-
rated in 1.0 mL of neurobasal media containing DNase I (1 mg/
mL) and soybean trypsin inhibitor (0.5 mg/mL) to obtain a
single-cell suspension. Dissociated neurons were centrifuged
(180g, 10 min, 4°C) through a cushion of 4% bovine serum
albumin (BSA) in HBSS. The cells were resuspended in neuro-
basal medium containing B27 supplements, 1% glutamine, 1%
penicillin/streptomycin, 25 mM glucose, and 25 mM KCl, and
seeded in poly-D-lysine/laminin-coated chamber slides (Becton
Dickenson) or dishes (MatTek). The CGN were cultured for 7 d
in vitro prior to measurement of Ca++ responses and for 12 d in
vitro for other studies.
Biochemical assays
Immunoblot analysis was performed using antibodies to cFyn
(Biolegends), JIP1 and JIP2 (Yasuda et al. 1999), the C terminus
of JIP1/2 (Santa Cruz Biotechnology), the C-terminal SH3 do-
main of JIP1/2 (Zymed), JNK1/2 (Pharmingen), phospho-JNK
(Cell Signaling), phosphotyrosine 4G10 (Upstate Biotechnol-
ogy), Flag tag (Sigma), -Tubulin (Sigma), -Tubulin (Covance),
NR1 (BD Pharmingen), NR2A and NR2B (Chemicon), phospho-
Ser1303-NR2B (Upstate Biotechnology), phospho-Tyr1472-
NR2B (Abcam), and T7 tag (Novagen). JNK activity was mea-
sured in an in vitro kinase assay using c-Jun as the substrate
(Whitmarsh and Davis 2001) and was quantitated using a Phos-
phorImager (Molecular Dynamics). Pull-down assays were per-
formed using bacterially expressed GST, GST-cFyn-SH2, or
GST-cFyn-SH3 (provided by A. Veillette, Clinical Research In-
stitute of Montreal, Montreal, Quebec, Canada) immobilized on
GSH-Sepharose using methods described previously (Whit-
marsh et al. 2001). Quantitative PCR analysis of mRNA expres-
sion was performed using TaqMan reagents and an Applied Bio-
systems real-time PCR machine using the manufacturer’s rec-
ommendations. Duplex PCR of the target mRNA and GAPDH
mRNA in a single well was performed, and the data are pre-
sented as the normalized ratio of [target mRNA]/[GAPDH
mRNA].
Transfection assays
COS7 cells (American Type Culture Collection) were cultured
in DMEM supplemented with 5% fetal bovine serum, tran-
siently transfected with expression vectors for cFyn (provided
by A. Veillette), JIP1 (Whitmarsh et al. 1998), or JIP2 (Yasuda et
al. 1999), and were harvested at 48 h post-transfection.
Immunofluorescence analysis
CGNs were fixed by incubation with 4% paraformaldehyde at
22°C (20 min). The cells were permeabilized with 0.1% Triton
X-100 or methanol (−20°C) for 5 min and incubated in blocking
buffer for 1 h (1% BSA, 2% normal goat serum in PBS). For
analysis of surface expression of NR1 and Reelin, cells were
fixed under nonpermeabilizing conditions by incubating with
4% paraformaldehyde and 4% sucrose for 8 min at 22°C fol-
lowed by incubation (1 h) in blocking buffer. Neurons were then
incubated in blocking buffer containing primary antibodies
GluR2 (Chemicon), LRP8 (provided by J. Nimpf), JIP1 (Santa
Cruz Biotechnology), phospho-JNK (Promega), -Tubulin (Co-
vance), NR1 (Chemicon), Synapsin-1 (Novus), and Reelin
(Chemicon). The primary antibodies were detected by incuba-
tion with anti-mouse or anti-rabbit Ig conjugated to Alexa Fluor
488 or 633 (Molecular Probes). Filamentous actin (phalloidin),
mitochondria (Mitotracker), cytoplasm (calcein), and DNA
(DAPI) were detected by staining (Molecular Probes). Fluores-
cence was visualized using a Leica TCS SP2 confocal micro-
scope equipped with a 405-nm diode laser. Potentially overlap-
ping emissions were collected separately using sequential scan-
ning. Fluorescence was quantitated using ImageJ (W.S. Rasband,
1997–2007; http://rsbinfonihgov/ij) and Image Pro Plus 5.0 (Me-
dia Cybernetics) software.
Cytoplasmic calcium
Neurons cultured in poly-D-lysine/laminin-coated glass-bot-
tom dishes (MatTec) were labeled by incubation (15 min) in
neurobasal medium supplemented with 1 µM Ca++ indicator
dye Fluo-4 AM (Molecular Probes) at 37°C. The cells were
washed and incubated (15 min) in neurobasal medium prior
to analysis. The cells were imaged using a Leica TCS SP2 scan-
ning confocal microscope (lex = 488 nm, lem = 500–560 nm) at
37°C with maximum continuous scan rate (512 × 512 pixels,
1.5 sec per frame). After a 10-frame baseline scan, the cells were
treated with 50 µM NMDA plus 200 µM glycine or depolarized
by addition of KCl (70 mM final concentration) during con-
tinuous imaging. Each experiment was terminated by addition
of 10 µM 4-Bromo-A23187 (Calbiochem) to determine the maxi-
mum fluorescence intensity and then 10 mM EGTA to deter-
mine the minimum fluorescence intensity. The free intracellu-
lar calcium concentration was calculated using the equation
[Ca2+]free = Kd[F − Fmin]/[Fmax − F], where Kd Fluo-4 is 345 nM
(Molecular Probes), and Fmin and Fmax are the fluorescence in-
tensities after treatment with 4-Bromo-A23187 and EGTA, re-
spectively (Grynkiewicz et al. 1985).
Electrophysiology
We used standard whole-cell recording (Hamill et al. 1981).
Patch electrodes, pulled from borosilicate capillary glass on a
horizontal Brown-Flaming puller (Sutter Instruments), were
fire-polished to a final resistance of 3–5 M, and filled with 90
mM Cs2SO4, 10 mM CsCl, 11 mM EGTA, 10 mM HEPES, and
0.5 mM CaCl2 (pH 7.35 with CsOH; osmolarity, 290–295
mOsM). Recordings in voltage-clamp mode (−60 mV) were ac-
quired at a sampling rate of 20 kHz and filtered at 6 kHz with an
EPC-10 double amplifier (HEKA Electronik). Series resistance,
between 10 and 15 M, was 70% compensated. Potentials were
not corrected for liquid junction potentials, estimated to be +2
mV.
Recording dishes were superfused with Mg++ and PO4-free
Hank’s buffered saline (120 mM NaCl, 10 mM KCl, 2.2 mM
CaCl2, 5 mM Glucose, 10 mM HEPES at pH 7.35). Drugs were
applied locally by gravity at a rate of 1.5 mL/sec, using a rapid
three-barrel capillary superfusion device (Warner Instrument)
with the pipette tips (700 µm diameter) placed ∼200 µm from
the recorded cell. The pipette assembly was attached to a motor,
allowing fast lateral motions controlled by the acquisition soft-
ware (PatchMaster 2.01; HEKA Electronik). A drug onset time of
20 msec for the application system was determined by measur-
ing the change in tip potential of the recording pipette filled
with intracellular solution as the perfusion was switched from
a normal to a 1:2 dilution of the extracellular recording solution.
After recording a stable current, CGN were exposed four con-
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secutive times (4 sec) to 500 µM NMDA (Sigma) plus 200 µM
glycine (Sigma), with a stimulation interval of 30 sec to avoid
possible current inactivation. We included 1 µM strychnine
(Sigma) in control and NMDA/glycine solutions to block the
possible activation of taurine receptors by glycine (Martin and
Siggins 2002). NMDA currents from wild-type and knockout
neurons were recorded on the same day. To ensure that differ-
ences in NMDA current amplitude between groups were not
caused by neurons with a larger membrane surface area, we
measured the membrane capacitance of each neuron as part of
our routine acquisition protocol. Peak NMDA current ampli-
tudes and desensitization rates averaged from four consecutive
traces were analyzed with PatchMaster 2.05 (HEKA Electronik).
The NMDA current was fitted with a single exponential using
∼40 iterations.
Statistical comparisons of the individual data sets employed
standard ANOVA and Tukey honest significant difference tests
for independent samples with unequal Ns as found in the basic
statistics module of Statistica (version 7.1, Statsoft).
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